roundhill glp-1 & weight loss etf The $OZEM top 10 holdings snapshot 👇 $NVO $LLY $ZEALDC $VKTX $ROGSW $GPCR $AMGN $PFE The TRUTH Behind the BEST

Given the rising prevalence of cardiorenal events in patients after AKD and the potential role of AKD in exacerbating these conditions, it is essential for healthcare providers to consider GLP-1 RAs treatment as an integral part of a comprehensive strategy to address this significant public health issue

The new GLP-1 RA users, SGLT-2 inhibitor users and DPP-4 inhibitor users were defined as a first-time redemption for prescription of drugs with anatomical therapeutic chemical (ATC) codes A10BJ (GLP-1), A10BH (DPP-4 inhibitors) or A10BK (SGLT-2 inhibitors)

Accessed 26 Feb 2024 Pazzagli L, Andersen M, Sessa M (2022) Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: a simulation study

doi: 10.1016/j.jagp.2023.08.010 [DOI] [PubMed] [Google Scholar] 82.Tang H, Lu Y, Donahoo WT, et al

Investigators used the TriNetX multi-institutional database to identify patients based on ICD-10 codes